Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects

Cancer Immunology Immunotherapy

Volumn 47, Issue 4, 1998, Pages 191-197

  Chen, Qiyuan ^a   Jackson, Heather ^a   Gibbs, Peter ^a   Davis, Ian D ^a   Trapani, Joseph ^b   Cebon, Jonathan ^c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

Cytotoxic lymphocytes; Differentiation antigens; Melan A; Melanoma

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; MATRIX PROTEIN; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MELANOMA; MIXED LYMPHOCYTE CULTURE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; NEOPLASM PROTEINS; OLIGOPEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032417654     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050520     Document Type: Article

References (28)

1. Anichini A, Mazzochi A, Fossati G, Parmiani G (1989) Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells:analysis of specificity and mechanisms of interaction. J Immunol 142:3692
2. Bakker AB, Marland G, de Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 55:5330
3. Boon T, Coulie PG, Van den Eynde B (1997) Tumor antigens recognized by T cells. Immunol Today 18:267
4. Brasseur F, Rimoldi D, Lienard D, Lethe B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, et al (1995) Expression of MAGE genes in primary and metastalic cutaneous melanoma. Int J Cancer 63:375
5. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489
6. + T-cell clones from regional lymph nodes of melanoma patients. Int J Cancer 51:218
7. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914
8. Coulie PG, Somville M, Lehmann F,. Hainaut P, Brasseur F, Devos R, Boon T (1992) Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer 50:289
9. Coulie PG, Brichard V, Van Pel A, Wolfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35
10. Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF (1991) MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol 146:1692
11. Darrow TL, Slingluff CL, Seigler HF (1989) The role of HLA class 1 antigens in recognition of melanoma cells by tumor-specific T lymphocytes. Evidence for shared tumor antigens. J Immunol 142:3329
12. de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GN (1997) Heterogeneous expression of immuno-therapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223
13. Herr W, Wolfel T, Heike M, Meyer zum Buschenfelde KH, Knuth A (1994) Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells. Cancer Immunol Immunother 39:93
14. Jäger K, Ringholler M, Arand M, Karbach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A (1996) Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res 6:419
15. Jäger E, Ringhoffer M, Dienes HP, Arand M, Karbach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A (1996) Granulocyte-macrophage-colony stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer 67:54
16. Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringholler M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A (1998) Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1:definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187:265
17. Kawakami Y, Zakut R, Topalian SL, Stotter H, Rosenberg SA (1992) Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol 148:638
18. Kawakami Y, Eliyahu S, Delgado CH, Robhins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458
19. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347
20. Loftus DJ, Castelli C, Clay TM, Squarcina P, Marincola FM, Nishimura MI, Parmiani G, Appella E, Rivoltini L (1996) Identification of epitope mimics recognized by CTL reactive to the melanoma melanocyte-derived peptide MART-1 (27 35). J Exp Med 184:647
21. Marincola FM, Rivoltini L, Salgaller ML, Player M, Rosenberg SA (1996) Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors:evidence of in vivo priming by tumor cells. J Immunother Emphasis Tumor Immunol 19:266
22. Romero P, Gervois N, Schneider J, Escobar P, Valmori D, Pannetier C, Steinle A, Wolfel T, Lienard D, Brichard V, van Pel A, Jotereau F, Cerottini JC (1997) Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J Immunol 159:2366
23. Salgaller ML, Afshar A, Marincola FM, Rivoltini L, Kawakami Y, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res 55:4972
24. Scott AM, Cebon J (1997) Clinical promise of tumour immunology. Lancet 349 [Suppl 2]:SII19
25. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, De Pluen E, Van Den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic lymphocytes on a human melanoma. Science 254:1643
26. van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJ, Schrier PI (1996) Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur J Immunol 26:168
27. Visseren MJ, van Elsas A, van der Voort El, Ressing ME, Kast WM, Schrier PI, Melief CJ (1995) CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J Immunol 154:3991
28. Wolfel T, Klehmann E, Muller C, Schutt KH, Meyer zum Buschenfelde KH, Knuth A (1989) Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med 170:797